Polatuzumab 是一种带有化疗活性分子的单克隆抗体。Polatuzumab 靶向 CD79b，CD79b 存在于 B 细胞表面。Polatuzumab 粘附在 CD79b 蛋白上并将化疗活性分子输送到细胞中。然后活性分子杀死细胞。Polatuzumab 可用于合成 Polatuzumab Vedotin。Polatuzumab Vedotin 是CD79b的抗体活性分子偶联物 (ADC)。

Human IgG1 Control was purified from Human serum by chromatography.Human IgG1 Control can be used as a Control, standard, blocking agent, or coating protein in a variety of experiments, including ELISA, Western and blotting, immunoprecipitation, and immunoelectrophoresis.Human IgG1 Control can also be used as an antigen or ligand in immunochemical conjugate reactions.

LSKL，血小板反应蛋白 (TSP-1) 抑制剂是一种源自潜伏相关肽的肽，可抑制 TGF-β 的血小板反应蛋白 (TSP-1) 激活。